1. Home
  2. BANX vs RANI Comparison

BANX vs RANI Comparison

Compare BANX & RANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ArrowMark Financial Corp.

BANX

ArrowMark Financial Corp.

HOLD

Current Price

$21.68

Market Cap

149.8M

Sector

Finance

ML Signal

HOLD

Logo Rani Therapeutics Holdings Inc.

RANI

Rani Therapeutics Holdings Inc.

HOLD

Current Price

$1.39

Market Cap

134.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BANX
RANI
Founded
2013
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
149.8M
134.6M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
BANX
RANI
Price
$21.68
$1.39
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$8.67
AVG Volume (30 Days)
23.4K
2.6M
Earning Date
06-17-2025
11-06-2025
Dividend Yield
9.66%
N/A
EPS Growth
N/A
N/A
EPS
2.35
N/A
Revenue
$29,467,794.00
$1,200,000.00
Revenue This Year
N/A
$414.59
Revenue Next Year
N/A
$30.15
P/E Ratio
$8.88
N/A
Revenue Growth
2.73
N/A
52 Week Low
$17.99
$0.39
52 Week High
$21.67
$3.87

Technical Indicators

Market Signals
Indicator
BANX
RANI
Relative Strength Index (RSI) 45.84 42.05
Support Level $22.06 $1.35
Resistance Level $22.50 $1.53
Average True Range (ATR) 0.32 0.11
MACD -0.05 -0.01
Stochastic Oscillator 25.23 15.52

Price Performance

Historical Comparison
BANX
RANI

About BANX ArrowMark Financial Corp.

ArrowMark Financial Corp is a non-diversified, closed-end management investment company. Its objective is to provide stockholders with current income, and to a lesser extent capital appreciation. The company's investments in various portfolios such as debt securities, Trust Preferred and Preferred Securities, preferred securities, exchange-traded funds, money market funds and others.

About RANI Rani Therapeutics Holdings Inc.

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.

Share on Social Networks: